Firstly want to say thanks for all the responses to my last post regarding my husbands dreadful side effects of Doxcetaxel. Each reply was encouraging and informative.
After 3 infusions with Doxcetaxel and horrendous side effects, my husbands psa has climbed to 900 which is alarming.
The therapy has been stopped and he will be having a couple of scans to see whats going on as he has lymph node involvement. He is CR but no bone involvement as yet "touch wood".
His Oncologist is suggesting other therapies but until scans are done in a couple of weeks he won't know what they will be. We really do not want to go on another Chemo treatment ie Cabitaxel as only having one kidney, one adrenal gland and no spleen, it's been really hard on his body.
Since being diagnosed 12 years ago he has had Radiation to the prostate bed, Adt for 3 yrs, stopped that as psa stabilized then watch and wait for 6 years then cancer returned so back on Adt and an Orchiectomy Adt failed as he became CR. Then he tried Xtandi for almost 1 year and it too failed, Doxcetaxal for 3 months and failed.
He has been tested for Braca1 and 2 and shows negative.
Any suggestions as to what would be a good next therapy.
Thank you
Written by
Knittingque
To view profiles and participate in discussions please or .
Cabazitaxel is different from docetaxel, it is generally better tolerated and more effective, it can also be done at a reduced dose. If there are no other therapies available and the physical conditions and blood tests allow it, it is worth trying. There would also be pluvicto but I do not know enough about this treatment, so I cannot tell you anything useful.
- Schedule appointment with Radiations Oncologist may be they can radiate it. Many times MO say no for radiations but still go and see radiations oncologist
- Can he try TALZENNA® in Combination with XTANDI ?
“The TALAPRO-2 results showed that TALZENNA plus XTANDI is the first and only PARP inhibitor in combination with an ARPI to significantly improve survival in patients with metastatic castration-resistant prostate cancer, regardless of mutation status,” said Roger Dansey, M.D., Chief Development Officer, Oncology, Pfizer. “Pfizer is dedicated to advancing scientific breakthroughs in genitourinary cancers, and these exciting TALAPRO-2 results further highlight our long-standing commitment to improving survival for men with prostate cancer.
A first step might be to request a biopsy of some of the metastases. Then they could do histology, IHC, and genomics. My "wish-list" for IHC (stains are not available everywhere) would be:
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
Importance of ADT
Bicalutamide?
PSA rising but scans clear
Fenbendazole probably not working for me
